Masanao Nasuno

Sapporo, 0640919, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Journal: Crohn's & colitis 360
Published: March 20, 2026

Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort.

Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort.

Journal: Inflammatory intestinal diseases
Published: February 18, 2026

Superb microvascular imaging within intestinal ultrasonography predicts endoscopic ulcers in the terminal ileum of patients with Crohn's disease.

Superb microvascular imaging within intestinal ultrasonography predicts endoscopic ulcers in the terminal ileum of patients with Crohn's disease.

Journal: Medicine
Published: November 16, 2025

Improvement in small-bowel and colonic lesions observed by intestinal ultrasonography in Crohn's disease treated with risankizumab.

Improvement in small-bowel and colonic lesions observed by intestinal ultrasonography in Crohn's disease treated with risankizumab.

Journal: Medicine
Published: October 20, 2025

Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative Colitis.

Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative Colitis.

Journal: Inflammatory intestinal diseases
Published: July 26, 2025

Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study.

Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study.

Journal: Crohn's & colitis 360
Published: January 31, 2024

Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn's disease in clinical remission.

Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn's disease in clinical remission.

Journal: Medicine
Published: August 11, 2023

Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study.

Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study.

Journal: Medicine
Published: November 21, 2020

Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Journal: Journal of Crohn's & colitis
Published: May 16, 2020

Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis.

Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 28, 2019

Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.

Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.

Journal: Digestion
Published: January 05, 2017

A case of Takayasu's arteritis detected in a patient with Crohn's disease following infliximab treatment.

A case of Takayasu's arteritis detected in a patient with Crohn's disease following infliximab treatment.

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: October 12, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026